Xpert Bladder Cancer Monitor to Predict Need for 2nd TURB “MoniTURB Trial”

Xpert Bladder Cancer Monitor to Predict Need for 2nd TURB “MoniTURB Trial” - MoniTURB Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014974

Enrollment

600

Registered

2018-09-07

Start date

2018-09-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67

Interventions

Group 1: Patients admitted to hospital for transurethral resection of a bladder tumor (TUR-B) will be enrolled. According to the EAU Guidelines, second TUR-B will be performed for intermediate and hig

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • patients 18 years or older, who provide written informed consent • patients with endoscopically diagnosed urinary bladder tumor (primary or recurrent) • Sceduled TUR-B within 6 weeks after enrollement

Exclusion criteria

Exclusion criteria: • BCG (Bacillus Calmette-Guerin) Instillation 6 weeks prior to TUR-B/Re-TUR-B

Design outcomes

Primary

Measure	Time frame
Malignant tumor at second TUR-B	—

Secondary

Measure	Time frame
Recurrence-free survival	—

Countries

Germany

Contacts

Public ContactIris Simon

Cepheid Europe

iris.simon@cepheid.com+31 (61) 326 7875

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026